ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,242Medicare Part D Prescriptions Filled, Including Refills

Rank: 303 out of 1111

$483K Total Retail Price of All Prescriptions

Rank: 237 out of 1111

301 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 4,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 331 216 1 2
LEVOTHYROXINE SODIUM 274 213 2 3
FUROSEMIDE 227 169 3 6
PRAVASTATIN SODIUM 227 136 3 17
OMEPRAZOLE 194 95 5 4
SIMVASTATIN 178 120 6 5
METFORMIN HCL 177 113 7 8
ATORVASTATIN CALCIUM 173 108 8 15
CRESTOR 160 112 9 33
HYDROCHLOROTHIAZIDE 152 96 10 11
POTASSIUM CHLORIDE 133 93 11 9
GLIMEPIRIDE 109 74 12 61
METOPROLOL SUCCINATE 107 57 13 20
ADVAIR DISKUS 106 47 14 43
GABAPENTIN 95 48 15 10
ACTOS 91 75 16 98
LOSARTAN POTASSIUM 85 57 17 34
GEMFIBROZIL 85 17 17 92
CELEBREX 81 53 19 81
SERTRALINE HCL 77 65 20 24
CYCLOBENZAPRINE HCL 74 40 R 21 37
METOPROLOL TARTRATE 71 41 22 12
ALLOPURINOL 70 67 23 36
AMLODIPINE BESYLATE 69 47 24 7
SPIRIVA 69 37 24 53
WARFARIN SODIUM 68 40 26 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 51 26 23
GLIPIZIDE 66 54 28 57
METFORMIN HCL ER 66 29 28 84
TAMSULOSIN HCL 63 44 30 28
CITALOPRAM HBR 62 32 31 14
NAMENDA 60 56 32 31
NEXIUM 59 27 33 26
LANTUS 56 35 34 46
CIPROFLOXACIN HCL 55 43 35 58
LOSARTAN-HYDROCHLOROTHIAZIDE 54 39 36 72
HYDRALAZINE HCL 53 33 37 155
DIGOXIN 50 39 38 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.